Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on X4 Pharmaceuticals (XFOR – Research Report) on January 14 and set a price ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Amicus (FOLD – Research Report), with a price ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Onto Innovation (NYSE:ONTO) with a ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald from ...

In a recent blog post, OpenAI CEO Sam Altman said that as OpenAI continues to advance it has moved beyond research to product ...

Cantor Fitzgerald initiated coverage on shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) in a research ...

Monday - Cantor Fitzgerald has initiated coverage on Onto Innovation Inc. (NYSE: NYSE:ONTO) shares with an Overweight rating and has set a price target of $250. The new rating is based on the firm ...

Cambridge Nutritional Sciences PLC has announced that Cantor Fitzgerald Europe has crossed the 5% threshold in its voting rights, now holding 5.207% of the total voting rights. This acquisition of ...

We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at where Amazon.com, Inc. (NASDAQ:AMZN) stands against the other AI stocks.

NEW YORK, Jan. 8, 2025 /PRNewswire/ -- Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it closed its initial public offering of 20,000,000 Class A ordinary ...